| Home > Departments > Center for Oncology > II. Department of Internal Medicine > Clinical Trial Center
The II. Department of Medicine (Hematology and Oncology) is actively supported by its own Clinical Trials Center. This Trials Center encourages and assists internal and external partners to fulfill international scientific and ethical standards in compliance with current guidelines and governmental regulations (AMG, ICH-GCP, GCP) in all aspects of clinical trials. Compliance with these standards warrants the protection of rights and the safety of our participants according to the declaration of Helsinki as well as high quality data aquisition.
The following aspects of quality assurance in clinical trials are of particular importance:
Frequent training of the Clinical Trials Center team
Quality assurance thru thorough information and profound communication
Establishment of standard operating procedures
Documentation according to ICH-GCP
An actual overview of our studies you may find here TrialFinder (11.5.2012)
We offer Phase I - III trials:
Phase I trials take place in a designated phase I unit
In order to further improve the standard of care in the treatment of malignant diseases, clinical trials are a prerequisite to achieve this goal.
You can find your contact persons here.
